Close Menu
    Facebook X (Twitter) Instagram
    KSA News TodayKSA News Today
    Facebook X (Twitter) Instagram
    • KSA
    • Business
    • Technology
    • Sports
    • Lifestyle
    KSA News TodayKSA News Today
    • KSA
    • Business
    • Technology
    • Sports
    • Lifestyle
    • Contact us
    KSA

    KFSH Successfully Implements Gene Therapy for Sickle Cell Disease

    Editorial TeamBy Editorial TeamApril 3, 2026
    Share Facebook Twitter Pinterest Copy Link Telegram LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    King Faisal Specialist Hospital & Research Centre (KFSH) successfully applied gene therapy in a patient with sickle cell disease by modifying hematopoietic stem cells to correct the underlying genetic defect, followed by reinfusion of the modified cells, as part of a clinical trial aimed at expanding treatment options for patients ineligible for allogeneic stem cell transplantation.

    The milestone reflects KFSH’s ongoing efforts to advance its gene therapy program, bridging clinical care with translational research. By leveraging patient-specific genetic profiles, the hospital is enabling more precise, personalized treatment approaches for complex conditions.

    Beyond addressing the root cause of disease, gene therapy has a meaningful impact on patients’ quality of life. It helps reduce the frequency of painful health crises and minimizes reliance on long-term supportive treatments such as blood transfusions and repeated hospital admissions. This, in turn, supports greater health stability, improved daily functioning, and a lower risk of long-term complications.

    The delivery of these therapies is supported by a robust clinical and regulatory framework, including comprehensive patient assessments, specialized treatment environments that meet strict safety and quality standards, and seamless collaboration across medical, research, and technical teams. All procedures are carried out in coordination with relevant health authorities and in line with internationally recognized standards.

    King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and North Africa and 12th globally among the world’s top 250 Academic Medical Centers for 2026 and recognized as the most valuable healthcare brand in the Kingdom and the Middle East according to Brand Finance 2025. It has also been listed by Newsweek among the World’s Best Hospitals 2025, the World’s Best Smart Hospitals 2026, and the World’s Best Specialized Hospitals 2026.

    Source: Riyadh Daily

    Previous Article“Technology will always be central to sustaining Mai Dubai” – Adrian DCunha, Head of IT
    Next Article Arab, Islamic states condemn Israeli death penalty law for Palestinians in West Bank

    Related Posts

    Saudi Arabia deports 11,915 illegal residents in a week

    November 21, 2026

    KSrelief Distributes 1,250 Food Baskets in Yemen’s Shabwa

    November 21, 2026

    Saudi Arabia calls for mutual guarantees for lasting regional security at Mediterranean Dialogues

    November 21, 2026
    Latest Posts

    Saudi Arabia deports 11,915 illegal residents in a week

    Saudi envoy presents credentials as non-resident ambassador to North Macedonia president

    KSrelief Distributes 1,250 Food Baskets in Yemen’s Shabwa

    Delivery orders surge 25% to over 129 million in Q3 2026

    Latest News

    Saudi Arabia deports 11,915 illegal residents in a week

    November 21, 2026

    KSrelief Distributes 1,250 Food Baskets in Yemen’s Shabwa

    November 21, 2026

    Saudi Arabia calls for mutual guarantees for lasting regional security at Mediterranean Dialogues

    November 21, 2026
    Facebook X (Twitter) Instagram Pinterest
    • KSA
    • Business
    • Technology
    • Sports
    • Lifestyle
    • Contact us
    2026. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.